SCHEMBL4092799

SCHEMBL4092799

C=CC(=O)OS(=O)(=O)C=Cc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 13/20 0.53
LMNA P02545 3/20 0.53
NFE2L2 Q16236 2/20 0.53
HTT P42858 1/20 0.42
KMT2A Q03164 1/20 0.41
ALDH1A1 P00352 2/20 0.40
GAA P10253 1/20 0.40
HDAC3 O15379 1/20 0.40
TNKS O95271 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HCAR2 Q8TDS4 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
TNKS2 Q9H2K2 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28035898 0.98 PPARG (0.51) PPARGLMNANFE2L2HTTKMT2A
SCHEMBL15902425 0.98 PPARG (0.51) PPARGLMNANFE2L2HTTKMT2A
SCHEMBL3857843 0.86 PPARG (0.56) PPARGLMNANFE2L2HTTALDH1A1
SCHEMBL3857849 0.82 HCAR2 (0.52) PPARGLMNANFE2L2HTTALDH1A1
SCHEMBL1462403 0.82 HCAR2 (0.52) PPARGLMNANFE2L2HTTALDH1A1
SCHEMBL27958532 0.81 PPARG (0.58) PPARGLMNANFE2L2HTTKMT2A
SCHEMBL28358616 0.81 PPARG (0.50) PPARGLMNANFE2L2HTTALDH1A1
SCHEMBL28358859 0.81 PPARG (0.50) PPARGLMNANFE2L2HTTALDH1A1
SCHEMBL6814187 0.79 PPARG (0.56) PPARGLMNANFE2L2HTTKMT2A
SCHEMBL7177827 0.78 PPARG (0.47) PPARGLMNANFE2L2HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112445090-B Toner and method for producing the same 佳能株式会社 2024-03-08 CN disclosed
US-11459410-B2 High-purity amphipathic arylsulfonic acid amine salt vinyl monomer and copolymer thereof TOSOH FINECHEM CORPORATION (JP) 2022-10-04 US disclosed
EP-3666753-A1 HIGH-PURITY AMPHIPATHIC ARYLSULFONIC ACID AMINE SALT VINYL MONOMER AND COPOLYMER THEREOF Tosoh Finechem Corporation (JP) 2020-06-17 EP disclosed
US-20200172643-A1 HIGH-PURITY AMPHIPATHIC ARYLSULFONIC ACID AMINE SALT VINYL MONOMER AND COPOLYMER THEREOF TOSOH FINECHEM CORPORATION (JP) 2020-06-04 US disclosed
CN-108779607-A Aqueous polymer dispersions, its purposes and the method for preparing aqueous polymer dispersions 凯米罗总公司 2018-11-09 CN disclosed
CN-108699775-A Composition for modifying the rheology of a pigmented coating, use thereof and pigmented coating 凯米罗总公司 2018-10-23 CN disclosed
EP-2058705-B1 Toner and image forming process CANON KK (JP) 2015-09-09 EP disclosed
CN-104053688-A Method for controlling size distribution of polymer particles during preparation of aqueous polymer dispersion, aqueous polymer dispersion and its use KEMIRA OYJ 2014-09-17 CN disclosed
US-8652737-B2 Toner and image forming process CANON KABUSHIKI KAISHA (JP) 2014-02-18 US disclosed
US-20090130582-A1 TONER AND IMAGE FORMING PROCESS CANON KABUSHIKI KAISHA (JP) 2009-05-21 US disclosed
EP-2058705-A1 Toner and image forming process Canon Kabushiki Kaisha (JP) 2009-05-13 EP disclosed
CN-101375435-A Electrochemical cell dissepiments EVEREADY BATTERY INC (US) 2009-02-25 CN disclosed
US-20060286479-A1 Toner for developing electrostatic latent image KYOCERA MITA CORPORATION 2006-12-21 US disclosed
US-6226488-B1 Fixing apparatus for controlling distance between heating means and guide member CANON KABUSHIKI KAISHA (JP) 2001-05-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11459410-B2 High-purity amphipathic arylsulfonic acid amine salt vinyl monomer and copolymer thereof SLC7A1, ARSA, STS PPARG 2559/4885LMNA 3624/4885NFE2L2 4745/4885
US-20200172643-A1 HIGH-PURITY AMPHIPATHIC ARYLSULFONIC ACID AMINE SALT VINYL MONOMER AND COPOLYMER THEREOF SLC7A1, ARSA, STS PPARG 2559/4885LMNA 3624/4885NFE2L2 4745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.